Results 161 to 170 of about 36,401 (249)

Global, regional and country‐specific burden of chronic kidney disease due to type 1 diabetes mellitus: A systematic analysis of the 2021 global disease burden study

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 6, Page 3397-3409, June 2025.
Abstract Aims Chronic kidney disease (CKD) affects individual welfare, healthcare systems and societal progress. Of the multifaceted etiological factors, type 1 diabetes mellitus (T1DM) is a prominent contributor to CKD. Materials and Methods We analysed the global incidence, prevalence, deaths and disability‐adjusted life‐years (DALYs) with age ...
Jianran Sun   +5 more
wiley   +1 more source

Highlighting the new consensus guidelines for managing people at risk of, and with early‐stage type 1 diabetes—Relevance to clinical care in the UK

open access: yes
Diabetic Medicine, Volume 42, Issue 6, June 2025.
Parth Narendran   +5 more
wiley   +1 more source

Case Report: Diazoxide-induced diabetic ketoacidosis in a patient with insulinoma. [PDF]

open access: yesFront Endocrinol (Lausanne)
Chin RT, Kiew JJ, Ho KY, Deepak DS.
europepmc   +1 more source

Clinical and Electrophysiological Characterization of Diabetic Neuropathy in a Sub‐Saharan African Cohort

open access: yesJournal of the Peripheral Nervous System, Volume 30, Issue 2, June 2025.
ABSTRACT Background Diabetic neuropathy (DN) is the most frequent complication of diabetes mellitus, contributing to increased morbidity and mortality. Previous clinical studies on DN in sub‐Saharan Africa (sSA) have used purely clinical approaches, potentially underestimating the true magnitude of this disease. This study was designed to determine the
Samuel Eric Chokote   +16 more
wiley   +1 more source

Home - About - Disclaimer - Privacy